We are proud to announce that the ISOLPHARM group will arrange a thematic workshop entitled ISOL technique for the production of medical radionuclides at the FisMat 2025 conference, which will take place in Venice from 7th to 11th July. Abstract Nuclear medicine is currently a field of increasing importance in the fight against cancer. The…
Read more
On December 12th, the ISOLPHARM 2024 annual meeting took place at the Legnaro National Laboratories of INFN. The Work Packages of the ADMIRAL and ISOLPHARM_CORE experiments showed their latest results according to the scheduled milestones, while the new SPES_MED experiment was kicked off. All presentations are available on the event’s Indico page. Thank you to…
Read more
The 3D scaffold bioprinting experiments for the ISOLPHARM project started at the beginning of 2024 with some geometry printing tests, where GelMa was cured under a DLP homemade printer with the main task of testing the printing resolution of the instrument. At the end of October the first test where the ink was a mixture…
Read more
In October 2024, the ISOLPHARM collaboration successfully performed the first clonogenic survival evaluation using silver-111 on cancer cells. In particular, the UMR-106 rat osteosarcoma cell line was tested. This result represents a first important experimental milestone reached by the ISOLPHARM radiobiology community, which includes groups from the Universities of Pavia (with the LENA facility), Padova,…
Read more
At the CAPiR lab of Catania a solution containing Ag-111 was injected in mice. The Bruker In-Vivo Xtreme was then used to acquire digital autoradiography images after several time points. This is the first time in which the collaboration acquires in-vivo images through the Ag-111 radiation.
A new publication entitled “Ag-111 phantom images with Cerenkov Luminescence Imaging and digital autoradiography within the ISOLPHARM project” have just been published in the journal Applied Radiation and Isotopes. This paper describes the imaging experiments performed with phantoms filled with Ag-111 produced at LENA in Pavia and imaged by the Bruker In-Vivo Xtreme device at…
Read more
The ISOLPHARM project 2023 annual meeting was held at the Legnaro National Laboratories of INFN on December 21st. The four Work Packages of ADMIRAL experiment presented their progress according to the planned milestones. All contributions are available on the event’s Indico page. Thanks to all the partecipants!
The ISOLPHARM chemistry group obtained a new publication entitled “Chromatographic separation of silver-111 from neutron-irradiated palladium target: toward direct labeling of radiotracers” in the journal EJNMMI Radiopharmacy and Chemistry. Congratulations to all the people involved in this research campaign!
Four master students of the Department of Physics and Astronomy of the University of Padova graduated in September with theses projects developed within the ISOLPHARM project. Nicola Zancopè analyzed and interpreted CLI and DRI images in view of a Ag-111 biodistribution experiment. Vittoria Pavanello studied the performance of the novel 2D imaging beta detector of…
Read more
ISOLPHARM earned a Special Mention at the 108th Congress of the Italian Physical Society (SIF) thanks to the communication “Radiobiological model for β-emitter radiopharmaceutical therapy in dynamic cell cultures in the framework of the ISOLPHARM project”, presented by Alberto Arzenton. The contribution, that was included in the Biophysics and Medical Physics section, has been published…
Read more
